Overview

Escitalopram in Schizophrenia in OCD- Open Label Study

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology
Phase:
Phase 4
Details
Lead Sponsor:
BeerYaakov Mental Health Center
Collaborator:
Lundbeck Israel
Treatments:
Citalopram
Dexetimide